Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Linda Harty Biography and Net Worth

Director of Syneos Health

Linda A. Harty is an independent director who joined our Board in March 2017, served as our Lead Independent Director from August 2017 to December 2018, and is a member of the Audit Committee and Compensation and Management Development Committee. From February 2010 to April 2017, Ms. Harty served as Vice President, Treasurer of Medtronic plc (NYSE:MDT), a global company specializing in medical technology, services and solutions. Ms. Harty also served as Executive Vice President, Treasurer at Cardinal Health (NYSE:CAH) and has held financial leadership positions at RTM Restaurant Group, BellSouth, ConAgra and Kimberly-Clark. Ms. Harty is on the board of directors at Parker Hannifin (NYSE:PH), a Fortune 250 global leader in motion and control technologies, where she serves as Chair of the Audit Committee and a member of the Nominating and Corporate Governance Committee. Ms. Harty is also on the board of directors of Wabtec Corporation (NYSE: WAB), a Fortune 500 leading global provider of equipment, systems, digital solutions and value-added services for freight and transit rail, where she serves as Chair of the Audit Committee and a member of the Nominating and Corporate Governance Committee. Ms. Harty is also on the board of directors of Chart Industries (NYSE: GTLS), a leading global manufacturer of highly engineered equipment servicing multiple market applications in the energy and industrial gas markets, where she serves as a member of the Audit Committee. Ms. Harty earned her undergraduate degrees in finance and economics from the University of Wisconsin – Oshkosh, and furthered her studies in accounting at Georgia State University, passing the CPA exam in 1991.

What is Linda S. Harty's net worth?: The estimated net worth of Linda S. Harty is at least $214,900.00 as of September 16th, 2024. Ms. Harty owns 5,000 shares of Syneos Health stock worth more than $214,900 as of November 15th. This net worth approximation does not reflect any other investments that Ms. Harty may own. Learn More about Linda S. Harty's net worth.
How do I contact Linda S. Harty?: The corporate mailing address for Ms. Harty and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on Linda S. Harty's contact information.
Has Linda S. Harty been buying or selling shares of Syneos Health?: Linda S. Harty has not been actively trading shares of Syneos Health during the past quarter. Most recently, Linda S. Harty sold 4,122 shares of the business's stock in a transaction on Monday, December 20th. The shares were sold at an average price of $97.02, for a transaction totalling $399,916.44. Learn More on Linda S. Harty's trading history.
Who are Syneos Health's active insiders?: Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Linda S. Harty Insider Trading History at Syneos Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/20/2021	Sell	4,122	$97.02	$399,916.44
3/29/2021	Sell	7,310	$76.49	$559,141.90	6,925

Linda S. Harty Buying and Selling Activity at Syneos Health

Syneos Health Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Today's Range

Now: $42.98

$42.97

$42.99

50 Day Range

MA: $42.86

$42.48

$42.98

2 Week Range

Now: $42.98

$22.89

$52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58

This company will win the AI race

From Porter & Company | Ad